medline.ch Onkologie Urologische Tumoren
Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 30. September 2022
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 7437  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 148724  
   
Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker-driven learning framework.
Sci Adv
Rossi SH, Newsham I, Pita S, Brennan K, Park G, Smith CG, Lach RP, Mitchell T, Huang J, Babbage A, Warren AY, Leppert JT, Stewart GD, Gevaert O, Massie CE, Samarajiwa SA.
PMID: 36170366 [PubMed - as supplied by publisher]


Biosensors for detection of prostate cancer: a review.
Biomed Microdevices
Sarkar S, Gogoi M, Mahato M, Joshi AB, Baruah AJ, Kodgire P, Boruah P.
PMID: 36169742 [PubMed - as supplied by publisher]


Efficacy of cabazitaxel in patients with metastatic castration-resistant prostate cancer: A single-center study in Japan.
Int J Urol
Yamamoto Y, Ishii M, Yoshimura A, Hayashi T, Kawamura N, Nagahara A, Nakai Y, Nakayama M, Kakimoto KI, Nishimura K.
PMID: 36168966 [PubMed - as supplied by publisher]


Establishment of a five-enzalutamide-resistance-related-gene-based classifier for recurrence-free survival predicting of prostate cancer.
J Cell Mol Med
Chen J, Meng J, Liu Y, Bian Z, Niu Q, Chen J, Zhou J, Zhang L, Zhang M, Liang C.
PMID: 36168930 [PubMed - as supplied by publisher]


A SelectMDx/magnetic resonance imaging-based nomogram to diagnose prostate cancer.
Cancer Rep (Hoboken)
Wagaskar VG, Levi M, Ratnani P, Sullimada S, Gerenia M, Schlussel K, Choudhury S, Gabriele M, Haas I, Haines K 3rd, Tewari A.
PMID: 36168681 [PubMed - as supplied by publisher]


Relationship between Androgen Deprivation Therapy and Normal-Tension Glaucoma in Patients with Prostate Cancer: A Nationwide Cohort Study.
Yonsei Med J
Ha JS, Lee HS, Park JY, Jeon J, Kim DK, Kim M, Hwang HS, Kim TH, Ahn HK, Cho KS.
PMID: 36168243 [PubMed - in process]


The endoplasmic reticulum stress response in prostate cancer.
Nat Rev Urol
de la Calle CM, Shee K, Yang H, Lonergan PE, Nguyen HG.
PMID: 36168057 [PubMed - as supplied by publisher]


Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway.
Nat Rev Urol
Barrett T, de Rooij M, Giganti F, Allen C, Barentsz JO, Padhani AR.
PMID: 36168056 [PubMed - as supplied by publisher]


Independent and joint associations of weightlifting and aerobic activity with all-cause, cardiovascular disease and cancer mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Br J Sports Med
Gorzelitz J, Trabert B, Katki HA, Moore SC, Watts EL, Matthews CE.
PMID: 36167669 [PubMed - as supplied by publisher]


ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer.
Eur Urol
Devos G, Tosco L, Baldewijns M, Gevaert T, Goffin K, Petit V, Mai C, Laenen A, Raskin Y, Van Haute C, Goeman L, De Meerleer G, Berghen C, Devlies W, Claessens F, Van Poppel H, Everaerts W, Joniau S.
PMID: 36167599 [PubMed - as supplied by publisher]


How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come.
Eur Urol
Schilham MGM, Rijpkema M, Scheenen T, Hermsen R, Barentsz JO, Michiel Sedelaar JP, Kusters-Vandevelde H, Kerkmeijer LGW, Somford DM, Gotthardt M.
PMID: 36167598 [PubMed - as supplied by publisher]


Meta-Analysis of Body Concentration of Polychlorinated Biphenyls and Prostate Cancer.
Toxicol Ind Health
Pourhassan B, Pourbabaki R, Omidi F, Kalantary S, Beigzadeh Z.
PMID: 36167526 [PubMed - as supplied by publisher]


How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice.
Arch Ital Urol Androl
De Rose AF, Vecco F, Ambrosini F, Malinaric R, Mantica G, Terrone C.
PMID: 36165488 [PubMed - indexed for MEDLINE]


Radical cystectomy for bladder urothelial carcinoma with aggressive variant histology.
Arch Ital Urol Androl
Mehrnoush V, Brennan L, Ismail A, Zakaria A, Elmansy H, Shahrour W, Prowse O, Kotb A.
PMID: 36165473 [PubMed - indexed for MEDLINE]


Magnetic resonance imaging target fusion biopsy vs. transrectal ultrasound-guided biopsy - A comparative study of ISUP score upgrading risk in the final radical prostatectomy specimen.
Arch Ital Urol Androl
Guimarães T, Gil M, Medeiros M, Andrade V, Guerra J, Pinheiro H, Fernandes F, Pina J, Lopes Dias J, Campos Pinheiro L.
PMID: 36165470 [PubMed - indexed for MEDLINE]


Targeted prostate biopsy: 68Ga-PSMA PET/CT vs. mpMRI in the diagnosis of prostate cancer.
Arch Ital Urol Androl
Pepe P, Pepe L, Tamburo M, Marletta G, Pennisi M, Fraggetta F.
PMID: 36165469 [PubMed - indexed for MEDLINE]


One step nucleic acid amplification (OSNA) for detection of lymph node metastasis during robotic radical prostatectomy for prostate cancer: A pilot study.
Arch Ital Urol Androl
Argun OB, Mourmouris P, Saglican Y, Doganca T, Tuna MB, Kayhan CK, Yalcinkaya O, Tufek I, Kara H, Obek C, Ince U, Tzelves L, Skolarikos A, Kural AR.
PMID: 36165467 [PubMed - indexed for MEDLINE]


Total renal volume and renal function after radical nephrectomy in renal neoplasm.
Nefrologia (Engl Ed)
Pampa-Saico S, Alexandru S, Pizarro-Sánchez MS, López-Picasso M, Puente-Suárez LG, Barba R, Liaño F.
PMID: 36165113 [PubMed - indexed for MEDLINE]


Comparative evaluation of long non-coding RNA-based biomarkers in the urinary sediment and urinary exosomes for non-invasive diagnosis of bladder cancer.
Mol Omics
Qiu T, Xue M, Li X, Li F, Liu S, Yao C, Chen W.
PMID: 36164958 [PubMed - as supplied by publisher]


HL-444 An Oncology Simulation Model to Estimate 10-Year Overall Survival, Progression-Free Survival, and Stem Cell Transplantation for Frontline, Stage III or IV Classic Hodgkin Lymphoma Based on the Overall Survival Update of the ECHELON-1 Trial: A United States Perspective.
Clin Lymphoma Myeloma Leuk
Phillips T, Migliaccio-Walle K, Yu K, Bloudek B, Liu N, Burke J.
PMID: 36164031 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 148724    Seite 1 von 7437  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1